These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18444894)

  • 1. New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.
    Dover LG; Bhatt A; Bhowruth V; Willcox BE; Besra GS
    Expert Rev Vaccines; 2008 May; 7(4):481-97. PubMed ID: 18444894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.
    Prabowo SA; Gröschel MI; Schmidt ED; Skrahina A; Mihaescu T; Hastürk S; Mitrofanov R; Pimkina E; Visontai I; de Jong B; Stanford JL; Cardona PJ; Kaufmann SH; van der Werf TS
    Med Microbiol Immunol; 2013 Apr; 202(2):95-104. PubMed ID: 23143437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
    Schito M; Migliori GB; Fletcher HA; McNerney R; Centis R; D'Ambrosio L; Bates M; Kibiki G; Kapata N; Corrah T; Bomanji J; Vilaplana C; Johnson D; Mwaba P; Maeurer M; Zumla A
    Clin Infect Dis; 2015 Oct; 61Suppl 3(Suppl 3):S102-18. PubMed ID: 26409271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.
    Liang Y; Wu X; Zhang J; Yang Y; Wang L; Bai X; Yu Q; Li N; Li Z
    Scand J Immunol; 2011 Jul; 74(1):42-6. PubMed ID: 21352251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards new TB vaccines: What are the challenges?
    Dockrell HM
    Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zero deaths from tuberculosis: progress, reality, and hope.
    Zumla A; Kim P; Maeurer M; Schito M
    Lancet Infect Dis; 2013 Apr; 13(4):285-7. PubMed ID: 23531385
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
    Baffoe-Bonnie A; Houpt ER; Turner L; Dodge D; Heysell SK
    Emerg Infect Dis; 2019 Nov; 25(11):2120-2121. PubMed ID: 31454310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.
    Rattan A; Kalia A; Ahmad N
    Emerg Infect Dis; 1998; 4(2):195-209. PubMed ID: 9621190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis.
    Afkhami S; Villela AD; D'Agostino MR; Jeyanathan M; Gillgrass A; Xing Z
    Front Immunol; 2020; 11():557809. PubMed ID: 33013927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent updates on drug resistance in Mycobacterium tuberculosis.
    Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
    J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen.
    Ahmad N; Khan AH; Syed Sulaiman SA; Javaid A
    Int J Mycobacteriol; 2015 Sep; 4(3):258-9. PubMed ID: 27649876
    [No Abstract]   [Full Text] [Related]  

  • 14. New treatment options for multidrug-resistant tuberculosis.
    Field SK; Fisher D; Jarand JM; Cowie RL
    Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new vaccines and drugs for TB: limitations and potential strategic errors.
    Orme IM
    Future Microbiol; 2011 Feb; 6(2):161-77. PubMed ID: 21366417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing drug-resistant tuberculosis: experiences from India.
    Katoch VM
    Expert Rev Anti Infect Ther; 2010 May; 8(5):493-6. PubMed ID: 20455676
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamics of multidrug resistant tuberculosis in Veracruz, México between 2002 and 2008.
    Zenteno-Cuevas R; Rubi A; Fuentes-Dominguez J; Lara-Gonzalez JL; Escobar-Mesa A
    J Infect Dev Ctries; 2010 Nov; 4(11):776-8. PubMed ID: 21252458
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surveillance of resistance to antitubercular drugs in Cuba, 2000-2009].
    Montoro E; Lemus D; Echemendia M; Diaz R; Mederos L; Martinez MR; Llop A; Llanes MJ
    Rev Panam Salud Publica; 2011 Dec; 30(6):615-8. PubMed ID: 22358412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis clinical trial update and the current anti-tuberculosis drug portfolio.
    Palomino JC; Martin A
    Curr Med Chem; 2013; 20(30):3785-96. PubMed ID: 23862617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.